Apyx Medical Corporation Sustainability Profile
Apyx Medical Corporation, commonly referred to as Apyx Medical, is a pioneering medical technology company headquartered in the United States. Founded in 1989, the company has established itself within the surgical and aesthetic markets, focusing on innovative solutions that enhance patient outcomes. Apyx Medical is renowned for its unique Renuvion® technology, which combines helium plasma and radiofrequency energy for precise tissue treatment. This cutting-edge approach sets it apart in the fields of cosmetic surgery and dermatology. With a commitment to advancing minimally invasive procedures, Apyx Medical has achieved significant milestones, including expanding its product offerings and gaining recognition for its contributions to the industry. The company continues to strengthen its market position through ongoing innovation and a dedication to improving surgical techniques.
DitchCarbon Score
How does Apyx Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apyx Medical Corporation's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apyx Medical Corporation's reported carbon emissions
Apyx Medical Corporation, headquartered in the US, currently does not have any reported carbon emissions data for the latest year. As such, there are no specific figures available regarding their Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not outlined any reduction targets or commitments related to climate initiatives. In the absence of emissions data and reduction initiatives, it is important to note that Apyx Medical Corporation has not publicly committed to any specific climate pledges or frameworks such as the Science Based Targets initiative (SBTi). This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, Apyx Medical Corporation may need to consider establishing measurable climate commitments to align with broader environmental goals.
How Carbon Intensive is Apyx Medical Corporation's Industry?
How Carbon Intensive is Apyx Medical Corporation's Location?
Apyx Medical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Apyx Medical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
